Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Manufactured in the United States
Receive your LMN: Once approved and purchased ($15), your Letter of Medical Necessity will be generated instantly and emailed to you within 24 hours
Senate Finance Committee report revealed, three companies Novo Nordisk, Sanofi and Eli Lilly control 99 percent of the marketplace and have worked in lockstep to limit competition and increase prices: Over The Past Decade, The Three Largest Manufacturers Of Insulin Novo Nordisk, Sanofi And Eli Lilly Aggressively Raised The List Price Of Their Insulin Products Absent Significant Advances In The Efficacy Of The Drugs. Sanofis long-acting insulin pens, Lantus SoloStar, increased from $303 in 2014 to $404 in 2019
Freebies for Researchers Who Go Big Orders over $75: Receive a FREE Vial Vault, our sleek, secure container to store your research vials
US$ 28.20
US$ 27.76
US$ 20.93
US$ 22.35
US$ 25.80
US$ 29.05
US$ 20.41
US$ 24.99
